Polyprenols of Ginkgo biloba Enhance Antibacterial Activity of Five Classes of Antibiotics

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Tao, Ran ^a   Wang, Chengzhang ^a   Ye, Jianzhong ^a   Zhou, Hao ^a   Chen, Hongxia ^a  

^a RESEARCH INSTITUTE OF FORESTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; ISOPRENOID; POLYMYXIN B; POLYPRENOL; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PENTANOL; PRENOL;

ARTICLE; BACTERIAL CELL; BACTERICIDAL ACTIVITY; CALCIUM MOBILIZATION ASSAY; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ESCHERICHIA COLI; GINKGO BILOBA; MICROEMULSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTICLE SIZE; PLANT LEAF; STAPHYLOCOCCUS AUREUS; ZETA POTENTIAL; CHEMISTRY; DRUG EFFECTS; HUMAN; MICROBIOLOGY; PATHOGENICITY; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; GENTAMICINS; GINKGO BILOBA; HUMANS; PENTANOLS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84985915556     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/4191938     Document Type: Article

References (27)

1. T. A. van Beek and P. Montoro, "Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals," Journal of Chromatography A, vol. 1216, no. 11, pp. 2002-2032, 2009.
2. A. N. Boldyrev, L. E. Bulychev, G. A. Buryak et al., "Peculiarities of development of antiviral preparations based on siberian silver fir (Abies sibirica) polyprenols for aerosol administration," Journal of Aerosol Science, vol. 31, no. 1, pp. S496-S497, 2000.
3. C.-Z. Wang, Z.-B. Shen, and L. Gao, "Pharmacology of polyprenols from Ginkgo biloba L. leaves in combination with chemotherapeutic drugs on tumor," Chemistry and Industry of Forest Products, vol. 23, no. 3, pp. 15-18, 2003.
4. 4-induced hepatotoxicity in rats," Fitoterapia, vol. 82, no. 6, pp. 834-840, 2011.
5. I. O. Fedotova, V. S. Sultanov, N. N. Kuznetsova, V. I. Roshchin, and T. V. Nikitina, "Effect of new polyprenol drug ropren on anxiety-depressive-like behavior in rats with experimental Alzheimer disease," Eksperimental'naia i Klinicheskaia Farmakologiia, vol. 73, no. 9, pp. 2-5, 2010.
6. R. Tao, C.-Z. Wang, and Z.-W. Kong, "Antibacterial/antifungal activity and synergistic interactions between polyprenols and other lipids isolated from Ginkgo biloba L. leaves," Molecules, vol. 18, no. 2, pp. 2166-2182, 2013.
7. T. Chojnacki, E. Swiezewska, and T. Vogtmann, "Polyprenols from plants-structural analogues of mammalian dolichols," Chemica Scripta, vol. 27, p. 209, 1987.
8. M. D. Hartley and B. Imperiali, "At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl-phosphates," Archives of Biochemistry and Biophysics, vol. 517, no. 2, pp. 83-97, 2012.
9. V. Cantagrel, D. J. Lefeber, B. G. Ng et al., "SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder," Cell, vol. 142, no. 2, pp. 203-217, 2010.
10. E. Ciepichal, M. Jemiola-Rzeminska, J. Hertel, E. Swiezewska, and K. Strzalka, "Configuration of polyisoprenoids affects the permeability and thermotropic properties of phospholipid/polyisoprenoid model membranes," Chemistry and Physics of Lipids, vol. 164, no. 4, pp. 300-306, 2011.
11. C. Valtersson, G. van Duyn, A. J. Verkleij, T. Chojnacki, B. De Kruijff, and G. Dallner, "The influence of dolichol, dolichol esters, and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes," The Journal of Biological Chemistry, vol. 260, no. 5, pp. 2742-2751, 1985.
12. R. S. Kalhapure, N. Suleman, C. Mocktar, N. Seedat, and T. Govender, "Nanoengineered drug delivery systems for enhancing antibiotic therapy," Journal of Pharmaceutical Sciences, vol. 104, no. 3, pp. 872-905, 2015.
13. B. F. Brehm-Stecher and E. A. Johnson, "Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone," Antimicrobial Agents and Chemotherapy, vol. 47, no. 10, pp. 3357-3360, 2003.
14. K. C. Wang and S.-I. Ohnuma, "Isoprenyl diphosphate synthases," Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1529, no. 1-3, pp. 33-48, 2000.
15. A. S. Safatov, A. N. Sergeev, L. N. Shishkina et al., "Effect of intramuscularly injected polyprenols on influenza virus infection in mice," Antiviral Chemistry and Chemotherapy, vol. 11, no. 3, pp. 239-246, 2000.
16. Q. Huang, H. Yu, and Q. Ru, "Bioavailability and delivery of nutraceuticals using nanotechnology," Journal of Food Science, vol. 75, no. 1, pp. R50-R57, 2010.
17. P. A. Cornwell and B. W. Barry, "Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil," Journal of Pharmacy and Pharmacology, vol. 46, no. 4, pp. 261-269, 1994.
18. P. Izquierdo, J. Esquena, T. H. F. Tadros et al., "Formation and stability of nano-emulsions prepared using the phase inversion temperature method," Langmuir, vol. 18, no. 1, pp. 26-30, 2002.
19. R.-F. Shang, G.-H. Wang, X.-M. Xu et al., "Synthesis and biological evaluation of new pleuromutilin derivatives as antibacterial agents," Molecules, vol. 19, no. 11, pp. 19050-19065, 2014.
20. M. J. Hall, R. F. Middleton, and D. Westmacott, "The fractional inhibitory concentration (FIC) index as a measure of synergy," Journal of Antimicrobial Chemotherapy, vol. 11, no. 5, pp. 427-433, 1983.
21. J. Gutierrez, C. Barry-Ryan, and P. Bourke, "Antimicrobial activity of plant essential oils using food model media: efficacy, synergistic potential and interactions with food components," Food Microbiology, vol. 26, no. 2, pp. 142-150, 2009.
22. V.H. Tam, S. Kabbara, G. Vo, A. N. Schilling, and E. A. Coyle, "Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa," Antimicrobial Agents and Chemotherapy, vol. 50, no. 8, pp. 2626-2631, 2006.
23. R. Tao, C. Z. Wang, Y. S. Zhang, J. Z. Jian, H. Zhou, and H. X. Chen, "Preparation of polyprenols nanoemulsion from Ginkgo biloba L. leaves polyprenols," Biomass Chemical Engineering, vol. 49, p. 7, 2015.
24. J. L. Kadurugamuwa, A. J. Clarke, and T. J. Beveridge, "Surface action of gentamicin on Pseudomonas aeruginosa," Journal of Bacteriology, vol. 175, no. 18, pp. 5798-5805, 1993.
25. J. Y. Lee, S. H. Lee, J. W. Chang, J.-J. Song, H. H. Jung, and G. J. Im, "Protective effect of metformin on gentamicininduced vestibulotoxicity in rat primary cell culture," Clinical and Experimental Otorhinolaryngology, vol. 7, no. 4, pp. 286-294, 2014.
26. N. H. Lam, Z. Ma, and B.-Y. Ha, "Electrostatic modification of the lipopolysaccharide layer: competing effects of divalent cations and polycationic or polyanionic molecules," Soft Matter, vol. 10, no. 38, pp. 7528-7544, 2014.
27. S. S. Krag, "The importance of being dolichol," Biochemical and Biophysical Research Communications, vol. 243, no. 1, pp. 1-5, 1998.